This also appears to be the case in MTC, in which an inverse correlation was observed in the current study between TIMP-2 staining and baseline calcitonin, tumor size, tumor stage and distant metastases, suggesting that increased levels of TIMP-2 may be a marker of low metastatic potential in medullary cancer. The gene discussed is TIMP2; the disease is neoplasm.